Projects

The aim of the Strategic Timing of AntiRetroviral Treatment (START) Neurology trial, is to investigate whether immediate initiation of antiretroviral treatment (ART) is superior to deferral of ART until the CD4+ declines below 350 cells/mm3 on neuropsychological functions.

This study is focused on how to determine the prevalence and incidence of HIV-associated neurocognitive disorders in Canada and to assess cognitive rehabilitation/training strategies.

This study focuses on HIV-associated neurocognitive disorder mechanisms in chronic and virally suppressed HIV infection as well as in patients who are aging and are at higer risks of cardiovascular diseases.

This project aims to develop a screening and standard neuropsychological battery that is cross-culturally valid for assessment of neurocognitive functions in HIV infection, in culturally and linguistically diverse Australians

This project is dedicated to the identification and quantification of HIV reservoirs biomarkers in the Central Nervous System.

We have developed a rating scale that will allow professionals to give better advice to families and patients, and will permit patients and families to make adjustments to their living arrangements.